|
|
|
|
GabitrilPharmaLive.com (press release), The company currently markets four proprietary products in the United States: PROVIGIL, GABITRIL(R) (tiagabine hydrochloride), ACTIQ(R) (oral transmucosal ... Cephalon CEO readies for 4 new drug launches Dec 19, 2005 Reuters The company is also studying its epilepsy drug Gabitril, which had $43 million in third-quarter sales, to treat general anxiety disorder, which has a much ... Subject: Jim Cramer's Action Alerts PLUS -- CEPH Jan 3, 2006 TheStreet.com (subscription), ...with a children's ADHD drug expected to be approved and hit the market this quarter, as well as the wrapping up of Phase III trials for its Gabitril drug to ... FDA Issues Approvable Letter for VIVITROL(TM) (Formerly VIVITREX(R ... Dec 28, 2005 Finanzen.net, The company currently markets four proprietary products in theUnited States: PROVIGIL(R) (modafinil) (C-IV), GABITRIL(R) (tiagabinehydrochloride), ACTIQ(R ... Cephalon, Inc. Completes Acquisition of Zeneus Holdings Limited Dec 22, 2005 Yahoo! News (press release) The company currently markets four proprietary products in the United States: PROVIGIL® (modafinil) [C-IV], GABITRIL® (tiagabine hydrochloride), ACTIQ ... Cephalon, Inc. Completes Acquisition of Zeneus Holdings Limited Dec 22, 2005 Boursorama, The company currently markets four proprietary products in the United States: PROVIGIL(R) (modafinil) [C-IV], GABITRIL(R) (tiagabine hydrochloride), ACTIQ(R ... The Exorcism of Emily Rose Dec 20, 2005 Filmcritic.com ...university physicians claim she's suffering from epileptic seizures and extreme psychosis that can be controlled by careful administration of the drug Gabitril ... |
|
Home Copyright phasechange.org 2006. All Rights Reserved. |